- Previous Close
74.00 - Open
73.80 - Bid 69.60 x --
- Ask 71.00 x --
- Day's Range
70.20 - 74.40 - 52 Week Range
34.00 - 79.00 - Volume
23,261 - Avg. Volume
33,504 - Market Cap (intraday)
1.342B - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
33.46 - EPS (TTM)
2.11 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
98.00
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
paxmanscalpcooling.comRecent News: PAX.ST
View MorePerformance Overview: PAX.ST
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PAX.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PAX.ST
View MoreValuation Measures
Market Cap
1.41B
Enterprise Value
1.38B
Trailing P/E
35.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.58
Price/Book (mrq)
8.58
Enterprise Value/Revenue
5.46
Enterprise Value/EBITDA
27.77
Financial Highlights
Profitability and Income Statement
Profit Margin
15.27%
Return on Assets (ttm)
10.62%
Return on Equity (ttm)
28.05%
Revenue (ttm)
263.2M
Net Income Avi to Common (ttm)
40.2M
Diluted EPS (ttm)
2.11
Balance Sheet and Cash Flow
Total Cash (mrq)
40.31M
Total Debt/Equity (mrq)
8.72%
Levered Free Cash Flow (ttm)
-7.54M